Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Rockefeller
Sloan Kettering
Tri-Institutional MD-PhD Program
Explore this Website
Home
About Us
Toggle About Us menu options
Welcome from Dr. Katharine Hsu
Welcome from Tri-I Students
Leadership and Staff
Our Institutions
Contact Us
Equal Education & Employment
Admissions
Toggle Admissions menu options
Admissions FAQs
Transfer Policy
Financial Support
Curriculum and Community
Toggle Curriculum and Community menu options
Program at a Glance
MD-PhD Specific Courses and Seminars
Tri-I Faculty
Student Directory
Belonging at Tri-I
Student Housing
Program FAQ
Tri-I Outcomes
Toggle Tri-I Outcomes menu options
Fellowships and Awards
Student Publications
Thesis Defenses
Residency Matches
Academic Career Progression
Career Paths of Our Alumni
Summer Program
Toggle Summer Program menu options
Gateways Admissions
Gateways To The Laboratory Summer Program FAQ
News and Events
Toggle News and Events menu options
Events Calendar
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Admissions
Curriculum and Community
Tri-I Outcomes
Summer Program
News and Events
Home
Biblio
Found 9 results
Filters:
Keyword
is
Pancreatic Neoplasms
[Clear All Filters]
2024
McIntyre CA, Grimont A, Park J, Meng Y, Sisso WJ, Seier K, Jang GHo, Walch H, Aveson VG, Falvo DJ et al.
. 2024.
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.
.
Cancer Cell. 42(9):1614-1629.e5.
2023
Burdziak C, Alonso-Curbelo D, Walle T, Reyes J, Barriga FM, Haviv D, Xie Y, Zhao Z, Zhao CJulia, Chen H-A et al.
. 2023.
Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis.
.
Science. 380(6645):eadd5327.
2022
Gartrell RD, Enzler T, Kim PS, Fullerton BT, Fazlollahi L, Chen AX, Minns HE, Perni S, Weisberg SP, Rizk EM et al.
. 2022.
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.
.
Oncoimmunology. 11(1):2066767.
2017
de Geus SWL, Eskander MF, Kasumova GG, Ng SChau, Kent TS, Mancias JD, Callery MP, Mahadevan A, Tseng JF
. 2017.
Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.
.
Cancer. 123(21):4158-4167.
Perez K, Clancy TE, Mancias JD, Rosenthal MH, Wolpin BM
. 2017.
When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.
.
J Clin Oncol. 35(5):485-489.
2016
Azzopardi S, Pang S, Klimstra DS, Du Y-CNancy
. 2016.
p53 and p16/p19 Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.
.
Neoplasia. 18(10):610-617.
David CJ, Huang Y-H, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massagué J
. 2016.
TGF-β Tumor Suppression through a Lethal EMT.
.
Cell. 164(5):1015-30.
2015
Rodić N, Steranka JP, Makohon-Moore A, Moyer A, Shen P, Sharma R, Kohutek ZA, Huang CRan, Ahn D, Mita P et al.
. 2015.
Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma.
.
Nat Med. 21(9):1060-4.
2012
Chenna V, Hu C, Pramanik D, Aftab BT, Karikari C, Campbell NR, Hong S-M, Zhao M, Rudek MA, Khan SR et al.
. 2012.
A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists.
.
Mol Cancer Ther. 11(1):165-73.